Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2020 08:00 ET | Source: Eyenovia, Inc.

Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea

Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs Arctic Vision to Lead Expansion of Novel...
July 29, 2020 08:30 ET | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results

NEW YORK, July 29, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
June 30, 2020 16:05 ET | Source: Eyenovia, Inc.

Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
June 11, 2020 16:10 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
June 05, 2020 16:10 ET | Source: Eyenovia, Inc.

Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format

NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
May 13, 2020 16:05 ET | Source: Eyenovia, Inc.

Eyenovia Reports First Quarter 2020 Financial Results

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
May 06, 2020 08:30 ET | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results

NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
March 25, 2020 16:05 ET | Source: Eyenovia, Inc.

Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results

NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
March 24, 2020 17:10 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement

NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
March 23, 2020 18:35 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement

NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...